Entity

Time filter

Source Type


The guidelines for peritoneal dialysis (PD) of the Japanese Society for Dialysis Treatment were prepared at 2009. Upon presenting a concrete frame of PD practiced in Japan, it aims to promote PD as a standardized therapy in Japan. Notably, the guidelines recommended combination therapy of PD and hemodialysis as a part of integrated renal replacement therapy for end-stage renal disease, as well as timely PD withdrawal by peritoneal degeneration in order to prevent progression of encapsulating peritoneal sclerosis. © 2010 The Authors. Journal compilation © 2010 International Society for Apheresis. Source


Haneda M.,Asahikawa University | Utsunomiya K.,Jikei University School of Medicine | Koya D.,Kanazawa Medical University | Babazono T.,Tokyo Womens Medical University | And 26 more authors.
Journal of the Japan Diabetes Society | Year: 2014

The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 ml/min/1.73 m2, regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages. Source


Makino H.,Japanese Society of Nephrology | Kimura K.,Japanese Society of Nephrology | Suzuki Y.,Japanese Society of Nephrology | Wada T.,Japanese Society of Nephrology | And 9 more authors.
Japanese Journal of Nephrology | Year: 2014

The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows : 1. eGFR can be used for the evaluation of GFR ; 2. In stage 3 (overt nephropathy), A and B were combined ; 3. Stage 4 (renal failure) was defined as GFR less than 30 mL/min/1.73 m2, regardless of albuminuria ; and 4. The importance of differential diagnosis was stressed in all stages. Source

Discover hidden collaborations